Total Payments
$79,834
2022 Payments
$14.06
Companies
12
Transactions
72
Medicare Patients
83
Medicare Billing
$21,268
Payment Breakdown by Category
Other$55,521 (69.5%)
Consulting$17,305 (21.7%)
Travel$5,034 (6.3%)
Food & Beverage$1,795 (2.2%)
Education$178.60 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $55,021 | 18 | 68.9% |
| Consulting Fee | $17,305 | 4 | 21.7% |
| Travel and Lodging | $5,034 | 17 | 6.3% |
| Food and Beverage | $1,795 | 28 | 2.2% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $500.00 | 1 | 0.6% |
| Education | $178.60 | 4 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $42,797 | 36 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $15,480 | 9 | $0 (2020) |
| Daiichi Sankyo Inc. | $10,822 | 2 | $0 (2019) |
| Boehringer Ingelheim Pharma GmbH & Co.KG | $4,201 | 2 | $0 (2020) |
| AbbVie, Inc. | $4,049 | 7 | $0 (2019) |
| Gilead Sciences, Inc. | $790.00 | 1 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $500.00 | 1 | $0 (2020) |
| Astellas Pharma US Inc | $375.06 | 2 | $0 (2020) |
| Celgene Corporation | $361.94 | 4 | $0 (2019) |
| Jazz Pharmaceuticals Inc. | $335.88 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $14.06 | 1 | Regeneron Healthcare Solutions, Inc. ($14.06) |
| 2020 | $40,034 | 30 | Incyte Corporation ($22,088) |
| 2019 | $39,149 | 32 | Incyte Corporation ($20,710) |
| 2018 | $551.42 | 7 | Jazz Pharmaceuticals Inc. ($307.84) |
| 2017 | $85.35 | 2 | Celgene Corporation ($57.31) |
All Payment Transactions
72 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/03/2022 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: ONCOLOGY | ||||||
| 12/22/2020 | Incyte Corporation | JAKAFI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,460.00 | General |
| Category: Hematology/Oncology | ||||||
| 12/16/2020 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $790.00 | General |
| 11/25/2020 | Incyte Corporation | JAKAFI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,690.00 | General |
| Category: Hematology/Oncology | ||||||
| 11/18/2020 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $118.99 | General |
| Category: Hematology/Oncology | ||||||
| 11/18/2020 | Incyte Corporation | JAKAFI (Drug) | Travel and Lodging | Cash or cash equivalent | $55.20 | General |
| Category: Hematology/Oncology | ||||||
| 11/04/2020 | Incyte Corporation | JAKAFI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,460.00 | General |
| Category: Hematology/Oncology | ||||||
| 10/30/2020 | Boehringer Ingelheim Pharma GmbH & Co.KG | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $2,100.50 | General |
| 10/30/2020 | Boehringer Ingelheim Pharma GmbH & Co.KG | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $2,100.50 | General |
| 10/28/2020 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $101.71 | General |
| Category: Hematology/Oncology | ||||||
| 08/18/2020 | E.R. Squibb & Sons, L.L.C. | — | Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | Cash or cash equivalent | $500.00 | General |
| 07/10/2020 | Incyte Corporation | JAKAFI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,920.00 | General |
| Category: Hematology/Oncology | ||||||
| 06/30/2020 | Incyte Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,460.00 | General |
| 06/30/2020 | Astellas Pharma US Inc | XOSPATA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $365.00 | General |
| Category: ONCOLOGY | ||||||
| 06/27/2020 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $2,620.00 | General |
| 02/25/2020 | Incyte Corporation | JAKAFI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,920.00 | General |
| Category: Hematology/Oncology | ||||||
| 02/21/2020 | Astellas Pharma US Inc | XOSPATA (Drug) | Education | In-kind items and services | $10.06 | General |
| Category: ONCOLOGY | ||||||
| 02/17/2020 | Incyte Corporation | JAKAFI (Drug) | Travel and Lodging | Cash or cash equivalent | $548.23 | General |
| Category: Hematology/Oncology | ||||||
| 02/17/2020 | Incyte Corporation | JAKAFI (Drug) | Travel and Lodging | Cash or cash equivalent | $278.96 | General |
| Category: Hematology/Oncology | ||||||
| 02/17/2020 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $24.36 | General |
| Category: Hematology/Oncology | ||||||
| 02/17/2020 | Incyte Corporation | JAKAFI (Drug) | Travel and Lodging | Cash or cash equivalent | $18.00 | General |
| Category: Hematology/Oncology | ||||||
| 02/17/2020 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $10.06 | General |
| Category: Hematology/Oncology | ||||||
| 02/17/2020 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $8.47 | General |
| Category: Hematology/Oncology | ||||||
| 02/17/2020 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $7.39 | General |
| Category: Hematology/Oncology | ||||||
| 02/17/2020 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $6.47 | General |
| Category: Hematology/Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 12 | 36 | $6,840 | $2,524 |
| 2020 | 3 | 71 | 230 | $115,908 | $18,744 |
Total Patients
83
Total Services
266
Medicare Billing
$21,268
Procedure Codes
4
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 36 | $6,840 | $2,524 | 36.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 25 | 126 | $65,646 | $10,418 | 15.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 33 | 88 | $44,528 | $7,385 | 16.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 13 | 16 | $5,734 | $941.52 | 16.4% |
About Dr. Aziz Nazha, MD
Dr. Aziz Nazha, MD is a Internal Medicine healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2012. The National Provider Identifier (NPI) number assigned to this provider is 1508132382.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aziz Nazha, MD has received a total of $79,834 in payments from pharmaceutical and medical device companies, with $14.06 received in 2022. These payments were reported across 72 transactions from 12 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($55,021).
As a Medicare-enrolled provider, Nazha has provided services to 83 Medicare beneficiaries, totaling 266 services with total Medicare billing of $21,268. Data is available for 2 years (2020–2023), covering 4 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology
- Location Cleveland, OH
- Active Since 03/27/2012
- Last Updated 06/29/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1508132382
Products in Payments
- JAKAFI (Drug) $33,937
- GLEEVEC (Drug) $9,460
- TASIGNA (Drug) $3,400
- XOSPATA (Drug) $375.06
- VYXEOS (Drug) $335.88
- Vidaza (Drug) $104.96
- LIBTAYO (Biological) $14.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Cleveland
C Martin Harris, Md, MD
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Marina Magrey, Md, MD
Internal Medicine — Payments: $491,321
Internal Medicine $491,321
Dr. Moshe Ornstein, Md Ma, MD MA
Internal Medicine — Payments: $250,140
Internal Medicine $250,140
Dr. Katherine Talcott, M.d, M.D
Internal Medicine — Payments: $248,994
Internal Medicine $248,994
Dr. Elliott Dasenbrook, Md, MD
Internal Medicine — Payments: $184,924
Internal Medicine $184,924
Syed Bukhari
Internal Medicine — Payments: $164,516
Internal Medicine $164,516